No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Atrial Fibrillation* / drug therapy
-
Cost-Benefit Analysis
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Stroke* / drug therapy
-
Stroke* / prevention & control
-
Warfarin
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Warfarin